Please try another search
For the six months ended 31 October 2019, Consort Medical plc revenues decreased 4% to £146M. Net income decreased 86% to £1.1M. Revenues reflect Aesica segment decrease of 11% to £81.1M, Europe segment decrease of 8% to £99.9M, United States segment decrease of 38% to £9.7M, Rest of the world segment decrease of 12% to £13.2M. Net income also reflects Aesica segment loss increase from £500K to £10.5M.
Period Ending: | Oct 31, 2019 | Apr 30, 2019 | Oct 31, 2018 | Apr 30, 2018 |
---|---|---|---|---|
Total Revenue | 146 | 152.6 | 152.5 | 157.4 |
Gross Profit | ||||
Operating Income | 3.2 | 4.2 | 11.4 | 11.9 |
Net Income | 1.1 | 2.8 | 7.7 | 9.1 |
Period Ending: | Oct 31, 2019 | Apr 30, 2019 | Oct 31, 2018 | Apr 30, 2018 |
---|---|---|---|---|
Total Assets | 478.7 | 465.6 | 470.3 | 472.1 |
Total Liabilities | 250.2 | 227.4 | 223.4 | 225.8 |
Total Equity | 228.5 | 238.2 | 246.9 | 246.3 |
Period Ending: | Oct 31, 2019 | Apr 30, 2019 | Oct 31, 2018 | Apr 30, 2018 |
---|---|---|---|---|
Period Length: | 6 Months | 12 Months | 6 Months | 12 Months |
Cash From Operating Activities | -0.1 | 34.6 | 19.5 | 32.4 |
Cash From Investing Activities | -8 | -23.4 | -8.3 | -22 |
Cash From Financing Activities | 9.4 | -19.1 | -8.6 | -8.9 |
Net Change in Cash | 1.3 | -7.9 | 2.7 | 2 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review